- Update on visiting scholars and visiting students – July 1, 2021
- Updated guidance for laboratory- and non-laboratory-based research at MIT – June 14, 2021
- New MIT Covid policies take effect today – June 7, 2021
- Requiring employees to be vaccinated, and other updates – June 1, 2021
- UROP updates, including summer 2021 participation – May 19, 2021
- Covid-19 travel policy
- Covid-19 impact on sponsored programs
- Environment, Health & Safety Covid-19 FAQ
- Funding opportunities specific to Covid-19
- International Scholars Office
- MIT Libraries’ service updates
- Postdoctoral Services
- Research Ramp-Up information
Facility use and access
On June 7, 2021, in accordance with guidance from the Commonwealth of Massachusetts and the City of Cambridge, MIT lifted all of its Covid-era limits on building occupancy, returning spaces to their pre-Covid capacities. What this means for MIT researchers and research staff:
- While capacity limits have been lifted, access to buildings remains restricted to members of the MIT community who are authorized to access campus using Covid Pass, with regular testing and attestations required. Covid Access authorizers and MIT gatekeepers may still limit access to certain areas via MIT occupant access points (see the MIT campus access map).
- Campus visitors may now enter non-residential campus buildings if accompanied by a Covid Pass user who is authorized to access buildings; such visitors must be escorted by a Covid Pass user while inside campus buildings. All visitors must follow MIT’s pre-Covid visitor policies, as well as posted Covid safety precautions. MIT research visitor guidelines are being updated to provide more detailed guidance.
- Well-fitted face coverings remain required in all MIT buildings except when an individual is eating, drinking, or alone in a fully enclosed space.
As announced on June 1, 2021, all MIT faculty and staff must be fully vaccinated by July 30, 2021, in order to work on campus. Exemptions to this requirement may be granted for medical or religious reasons.
See the MIT Research Ramp-Up Information page for detailed guidance.
Specific research considerations
- Researchers are reminded that work with nucleic acids encoding for any portion of the SARS-CoV-2 genome may not begin without approval from the MIT Committee on Assessment of Biohazards & Embryonic Stem Cell Research Oversight (CAB/ESCRO) (MIT certificate required). Consult your biosafety officer for more information. If you are planning to work with the SARS-CoV-2 N gene (Nucleocapsid), please review the guidance document for amplifying the SARS-CoV-2 N gene (MIT certificate required).
- All requests to start or restart human subject research must be submitted through COUHES Connect and must be approved by COUHES before starting/restarting. Please note that COUHES approval is necessary but not sufficient for the resumption of human subject research; additional policies may also apply.
- Effective May 17, 2021, those who have been completely vaccinated and do not have symptoms after travel can return to their residence or work site immediately.
- Effective June 1, Covid-19 vaccination is required for MIT-related domestic and international travel. The requirement does not apply to local travel within New England.
- MIT community members are advised to review MIT travel resources and register travel in the Covid Pass app.
- See the MIT Covid-19 travel policy for more information.